I. Information about psychiatric drugs
“This story is the first in a two-part investigative special on problems in the clinical trials industry. The second, which asks why disgraced doctors are allowed to test drugs on human volunteers, is available here.”
Psychiatric drugs are doing us more harm than good The Guardian Wednesday 30 April2014 16.35 BST.
“As with benzodiazepines in the 1980s, the UK is prescribing SSRI antidepressants at a staggering rate – and to no good effect.” “My studies of the research literature in this whole area lead me to a very uncomfortable conclusion: the way we currently use psychiatric drugs is causing more harm than good. We should therefore use them much less, for shorter periods of time, and always with a plan for tapering off, to prevent people from being medicated for the rest of their lives.” ―Peter C. Gøtzsche
Dear Sirs, Council for Evidence-based Psychiatry (CEP),
I think that your concerns regarding psychiatric drugs, explained with great detail and cogent arguments through your website, are legitimate and well-founded.(1) I also found the response by Nutt and colleagues shameful and insulting, I’ll like to express here my firm intention to answer that letter in The Lancet.
1. Re: Putting GlaxoSmithKline to the test over paroxetine
Jorge H. Ramírez
Assistant Professor of Pharmacology
Universidad del Valle, Cali, Colombia.
II. Unanswered questions
https://twitter.com/Jor_H_R/status/441116428339380225 https://twitter.com/Jor_H_R/status/450472178501570560 https://twitter.com/Jor_H_R/status/450476482457251840 https://twitter.com/Jor_H_R/status/473009139497852928
Bienvenido al XXVIII Congreso APAL 2014 – Cartagena de Indias, Colombia